SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001213900-20-022410
Filing Date
2020-08-17
Accepted
2020-08-17 09:02:54
Documents
2

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea125534-8k_delmarphar.htm 425 28005
2 JOINT PRESS RELEASE, DATED AUGUST 17, 2020, ISSUED BY DELMAR PHARMACEUTICALS, IN ea125534ex99-1_delmar.htm EX-99.1 16740
  Complete submission text file 0001213900-20-022410.txt   46385
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
DelMar Pharmaceuticals, Inc. (Filed by) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4365 US 1 SOUTH, STE 211 PRINCETON NJ 08540
Business Address 4365 US 1 SOUTH, STE 211 PRINCETON NJ 08540 609-917-9784
Adgero Biopharmaceuticals Holdings, Inc. (Subject) CIK: 0001657598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 333-216052 | Film No.: 201108064
SIC: 2834 Pharmaceutical Preparations